secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001628280-26-028852
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health Q1 2026 net income $46.8M, diluted EPS $6.52, revenue $216.5M
--------------------------------------------------------------------------

- Revenue $216.5M (+2.2% YoY); hospital division revenue $207.6M.
- Net income attributable to Nutex $46.8M (diluted EPS $6.52) vs $21.2M ($3.33) YoY.
- Adjusted EBITDA $57.6M vs $72.8M YoY; operating cash flow $75.5M.
- Board approved self-development of hospital facilities; plans 3-5 hospitals/year.
- Cash $207.3M record high; long-term debt net $24.3M down from $29.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000162828026028852/0001628280-26-028852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000162828026028852/nutx-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-028852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer